Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
Price:
0.521
USD
-3.52%
Market Closed
Market Cap:
$2.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Trenders Inc
TSE:6069
|
JP |
|
A
|
Abist Co Ltd
TSE:6087
|
JP |
Galmed Pharmaceuticals Ltd
Other Items
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Galmed Pharmaceuticals Ltd
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD
|
Other Items
-$8.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
9%
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Other Items
$8k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-53%
|
|
|
Enlivex Therapeutics Ltd
NASDAQ:ENLV
|
Other Items
$11.5m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Other Items
$61.8m
|
CAGR 3-Years
261%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Other Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pluri Inc
NASDAQ:PLUR
|
Other Items
$7.2m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
17%
|
|
No Stocks Found
Galmed Pharmaceuticals Ltd
Glance View
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).
GLMD
Intrinsic Value
3.767
USD
Undervaluation 86%
See Also
What is Galmed Pharmaceuticals Ltd's Other Items?
Other Items
-8.4m
USD
-8.4m
USD
Based on the financial report for Sep 30, 2025, Galmed Pharmaceuticals Ltd's Other Items amounts to -8.4m USD.
What is Galmed Pharmaceuticals Ltd's Other Items growth rate?
Other Items CAGR 10Y
9%
9%
